These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 29399049)
1. Brivaracetam: a novel antiepileptic drug for focal-onset seizures. Stephen LJ; Brodie MJ Ther Adv Neurol Disord; 2018; 11():1756285617742081. PubMed ID: 29399049 [TBL] [Abstract][Full Text] [Related]
2. Narrative Review of Brivaracetam: Preclinical Profile and Clinical Benefits in the Treatment of Patients with Epilepsy. Klein P; Bourikas D Adv Ther; 2024 Jul; 41(7):2682-2699. PubMed ID: 38811492 [TBL] [Abstract][Full Text] [Related]
3. Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures. Mumoli L; Palleria C; Gasparini S; Citraro R; Labate A; Ferlazzo E; Gambardella A; De Sarro G; Russo E Drug Des Devel Ther; 2015; 9():5719-25. PubMed ID: 26543353 [TBL] [Abstract][Full Text] [Related]
4. Brivaracetam in the treatment of epilepsy: a review of clinical trial data. Feyissa AM Neuropsychiatr Dis Treat; 2019; 15():2587-2600. PubMed ID: 31571877 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study. Asadi-Pooya AA; Sperling MR; Chung S; Klein P; Diaz A; Elmoufti S; Schiemann J; Whitesides J Epilepsy Res; 2017 Mar; 131():70-75. PubMed ID: 28279891 [TBL] [Abstract][Full Text] [Related]
6. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial. Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083 [TBL] [Abstract][Full Text] [Related]
7. Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial. Kwan P; Trinka E; Van Paesschen W; Rektor I; Johnson ME; Lu S Epilepsia; 2014 Jan; 55(1):38-46. PubMed ID: 24116853 [TBL] [Abstract][Full Text] [Related]
8. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial. Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953 [TBL] [Abstract][Full Text] [Related]
9. Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment. Klitgaard H; Matagne A; Nicolas JM; Gillard M; Lamberty Y; De Ryck M; Kaminski RM; Leclercq K; Niespodziany I; Wolff C; Wood M; Hannestad J; Kervyn S; Kenda B Epilepsia; 2016 Apr; 57(4):538-48. PubMed ID: 26920914 [TBL] [Abstract][Full Text] [Related]
10. Brivaracetam as adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy: the current evidence base. Brandt C; May TW; Bien CG Ther Adv Neurol Disord; 2016 Nov; 9(6):474-482. PubMed ID: 27800023 [TBL] [Abstract][Full Text] [Related]
11. Adjunctive brivaracetam - A prospective audit of outcomes from an epilepsy clinic. Stephen L; Brodie MJ Epilepsy Behav; 2021 Mar; 116():107746. PubMed ID: 33517200 [TBL] [Abstract][Full Text] [Related]
12. Conversion to brivaracetam monotherapy for the treatment of patients with focal seizures: Two double-blind, randomized, multicenter, historical control, Phase III studies. Arnold S; Badalamenti V; Diaz A; Gasalla T; McShea C; Whitesides J; Fakhoury T Epilepsy Res; 2018 Mar; 141():73-82. PubMed ID: 29486396 [TBL] [Abstract][Full Text] [Related]
13. Efficacy, safety, and tolerability of adjunctive brivaracetam for secondarily generalized tonic-clonic seizures: Pooled results from three Phase III studies. Moseley BD; Sperling MR; Asadi-Pooya AA; Diaz A; Elmouft S; Schiemann J; Whitesides J Epilepsy Res; 2016 Nov; 127():179-185. PubMed ID: 27608437 [TBL] [Abstract][Full Text] [Related]
14. A review of the pharmacology and clinical efficacy of brivaracetam. Klein P; Diaz A; Gasalla T; Whitesides J Clin Pharmacol; 2018; 10():1-22. PubMed ID: 29403319 [TBL] [Abstract][Full Text] [Related]
15. Evidence for a differential interaction of brivaracetam and levetiracetam with the synaptic vesicle 2A protein. Wood MD; Gillard M Epilepsia; 2017 Feb; 58(2):255-262. PubMed ID: 28012162 [TBL] [Abstract][Full Text] [Related]
16. Brivaracetam efficacy and safety in focal epilepsy. Makke Y; Abou-Khalil B Expert Rev Neurother; 2019 Oct; 19(10):955-964. PubMed ID: 31195850 [No Abstract] [Full Text] [Related]
17. Profile of brivaracetam and its potential in the treatment of epilepsy. Ferlazzo E; Russo E; Mumoli L; Sueri C; Gasparini S; Palleria C; Labate A; Gambardella A; De Sarro G; Aguglia U Neuropsychiatr Dis Treat; 2015; 11():2967-73. PubMed ID: 26664121 [TBL] [Abstract][Full Text] [Related]
18. Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action. Nicolas JM; Hannestad J; Holden D; Kervyn S; Nabulsi N; Tytgat D; Huang Y; Chanteux H; Staelens L; Matagne A; Mathy FX; Mercier J; Stockis A; Carson RE; Klitgaard H Epilepsia; 2016 Feb; 57(2):201-9. PubMed ID: 26663401 [TBL] [Abstract][Full Text] [Related]
19. Brivaracetam augments short-term depression and slows vesicle recycling. Yang X; Bognar J; He T; Mohammed M; Niespodziany I; Wolff C; Esguerra M; Rothman SM; Dubinsky JM Epilepsia; 2015 Dec; 56(12):1899-909. PubMed ID: 26515103 [TBL] [Abstract][Full Text] [Related]
20. Effect of lifetime antiepileptic drug treatment history on efficacy and tolerability of adjunctive brivaracetam in adults with focal seizures: Post-hoc analysis of a randomized, placebo-controlled trial. Klein P; McLachlan R; Foris K; Nondonfaz X; Elmoufti S; Dimova S; Brandt C Epilepsy Res; 2020 Nov; 167():106369. PubMed ID: 32717713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]